Chinese medicinal herb decoction for treating thrombocytopenia after radio-chemotherapy

Abstract

The invention relates to the field of medicament formulation, in particular to a Chinese medicinal herb decoction for treating a thrombocytopenia after a radio-chemotherapy. The Chinese medicinal herb decoction is characterized by comprising the following steps of: using eclipta prostrate, agrimonia pilosa, cornus officinalis, spatholobus suberectus, radix rehmanniae, rheum officinale, pyrrosia lingua, callicarpa bodinieri, cephalanoplos segetum and raw licorice as raw material medicaments; mixing the raw material medicaments and soaking the mixture with water; and boiling out the mixture andremoving dregs to obtain filtrate. The raw material medicaments comprise the following ingredients in parts by weight: 15-30 parts of the eclipta prostrate, 9-15 parts of the agrimonia pilosa, 6-30 parts of the cornus officinalis, 9-30 parts of the spatholobus suberectus, 9-30 parts of the radix rehmanniae, 3-12 parts of the rheum officinale, 9-15 parts of the pyrrosia lingua, 9-15 parts of the callicarpa bodinieri, 9-15 parts of the cephalanoplos segetum and 3-15 parts of the raw licorice. The Chinese medicinal herb decoction provided by the invention has obvious effects of reinforcing liverand kidney, nourishing Yin and blood, and cooling blood to stop bleeding. After patients take the Chinese medicinal herb decoction, no toxic and side effects are generated, and therefore, the Chinesemedicinal herb decoction is suitable for treating the thrombocytopenia after the radio-chemotherapy and the treatment efficiency is high.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a Chinese medicine decoction for treating thrombocytopenia after radiotherapy and chemotherapy. Background technique [0002] As we all know, malignant tumors are increasing all over the world, and the incidence of malignant tumors in my country is also increasing year by year. At present, surgery, radiotherapy, and chemotherapy are still the three main treatment methods for tumors. Most chemotherapeutic drugs have strong cytotoxicity, can cause myelosuppression, and will lead to the decrease of white blood cells and platelets in patients. Due to the long life of red blood cells, the impact on white blood cells and platelets is relatively small, so the impact on white blood cells and platelets is more pronounced. significantly. A decrease in white blood cells can lead to hypoimmunity, and a decrease in platelets may lead to bleeding disorders. In recent years, with the ...

AI Technical Summary

Problems solved by technology

In recent years, with the successful development and application of granulocyte colony-stimulating factor, leukopenia has been reliably guaranteed during radiotherapy and chemotherapy. Short time, lack of blood source, expensive, and possible transfusion reaction, blood-borne infection, platelet antibody production, etc.

Although recombinant interleukin II and thrombopoietin have good curative effects, they have large adverse reactions and high prices

Images